Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
International Journal of Molecular Sciences · 20.02.2023 · 24 (4) · 4178
DOI: 10.3390/ijms24044178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.02.2023. Verfasst von Beatrice Moccaldi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medicine-DIMED, Padova University Hospital, 35128 Padova, Italy. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary, Connective Tissue Diseases, Hypertension. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a life-threatening complication of connective tissue diseases (CTDs) characterised by increased pulmonary arterial pressure and pulmonary vascular resistance. CTD-PAH is the result of a complex interplay among endothelial dysfunction and vascular remodelling, autoimmunity and inflammatory changes, ultimately leading to right heart dysfunction and failure. Due to the non-specific nature of the early symptoms and the lack of consensus on screening strategies—except for systemic sclerosis, with a yearly transthoracic echocardiography as recommended—CTD-PAH is often diagnosed at an advanced stage, when the pulmonary vessels are irreversibly damaged. According to the current guidelines, right heart catheterisation is the gold standard for the diagnosis of PAH; however, this technique is invasive, and may not be available in non-referral centres. Hence, there is a need for non-invasive tools to improve the early diagnosis and disease monitoring of CTD-PAH. Novel serum biomarkers may be an effective solution to this issue, as their detection is non-invasive, has a low cost and is reproducible. Our review aims to describe some of the most promising circulating biomarkers of CTD-PAH, classified according to their role in the pathophysiology of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Department of Medicine-DIMED, Padova University Hospital, 35128 Padova, Italy.
- Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.
ORCID-Profile: Andrea Doria
Zitieren
APA
Moccaldi, B., De Michieli, L., Binda, M., Famoso, G., Depascale, R., Perazzolo Marra, M., Doria, A., & Zanatta, E. (2023). Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 24(4), 4178. https://doi.org/10.3390/ijms24044178
Vancouver
Moccaldi B, De Michieli L, Binda M, Famoso G, Depascale R, Perazzolo Marra M, et al. Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2023;24(4):4178. doi:10.3390/ijms24044178
BibTeX
@article{Moccaldi2023,
author = {Moccaldi, Beatrice and De Michieli, Laura and Binda, Marco and Famoso, Giulia and Depascale, Roberto and Perazzolo Marra, Martina and Doria, Andrea and Zanatta, Elisabetta},
title = {Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4178},
doi = {10.3390/ijms24044178}
}
EUVIMED